Theravance Biopharma, Inc. (TBPH): SCHEDULE 13D/A filed Mar 25, 2026

Form type

SCHEDULE 13D/A

Filing date

Mar 25, 2026

Accession number

0001193125-26-124073

Filer

Theravance Biopharma, Inc. (CIK 1583107)